H. Deckx

430 total citations
19 papers, 323 citations indexed

About

H. Deckx is a scholar working on Rheumatology, Infectious Diseases and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, H. Deckx has authored 19 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rheumatology, 5 papers in Infectious Diseases and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in H. Deckx's work include Osteoarthritis Treatment and Mechanisms (8 papers), HIV/AIDS drug development and treatment (4 papers) and HIV-related health complications and treatments (4 papers). H. Deckx is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (8 papers), HIV/AIDS drug development and treatment (4 papers) and HIV-related health complications and treatments (4 papers). H. Deckx collaborates with scholars based in Belgium, United States and France. H. Deckx's co-authors include Simon Vanveggel, Michael Sension, Chloe Orkin, Marita Stevens, David A. Wohl, F. Eckstein, J.E. Dumont, Bernard Contempré, María Pueyo and A. T. Diplock and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Clinical Nutrition and Clinical Infectious Diseases.

In The Last Decade

H. Deckx

19 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Deckx Belgium 11 120 105 81 78 41 19 323
M. Chen Taiwan 4 46 0.4× 43 0.4× 20 0.2× 22 0.3× 5 0.1× 4 300
P.P. Koopmans Netherlands 8 44 0.4× 22 0.2× 7 0.1× 34 0.4× 3 0.1× 15 173
John Ayodele Olaniyi Nigeria 11 35 0.3× 39 0.4× 14 0.2× 5 0.1× 40 1.0× 31 246
Danny Li United States 6 65 0.5× 148 1.4× 17 0.2× 75 1.0× 13 0.3× 8 248
Can Küçük Türkiye 12 33 0.3× 42 0.4× 7 0.1× 3 0.0× 12 0.3× 33 395
Renu Misra India 12 37 0.3× 27 0.3× 32 0.4× 8 0.2× 19 341
Müferet Ergüven Türkiye 12 36 0.3× 9 0.1× 44 0.5× 1 0.0× 25 0.6× 57 364
Idy Tam United States 14 20 0.2× 122 1.2× 34 0.4× 7 0.2× 31 510
Anna-Carin Norlin Sweden 10 39 0.3× 6 0.1× 6 0.1× 5 0.1× 89 2.2× 13 360

Countries citing papers authored by H. Deckx

Since Specialization
Citations

This map shows the geographic impact of H. Deckx's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Deckx with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Deckx more than expected).

Fields of papers citing papers by H. Deckx

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Deckx. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Deckx. The network helps show where H. Deckx may publish in the future.

Co-authorship network of co-authors of H. Deckx

This figure shows the co-authorship network connecting the top 25 collaborators of H. Deckx. A scholar is included among the top collaborators of H. Deckx based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Deckx. H. Deckx is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Schnitzer, Thomas J., María Pueyo, H. Deckx, et al.. (2023). Evaluation of S201086/GLPG1972, an ADAMTS-5 inhibitor, for the treatment of knee osteoarthritis in ROCCELLA: a phase 2 randomized clinical trial. Osteoarthritis and Cartilage. 31(7). 985–994. 26 indexed citations
2.
Schnitzer, Thomas J., María Pueyo, H. Deckx, et al.. (2021). Efficacy and safety of s201086/GLPG1972, an ADAMTS-5 inhibitor, in patients with knee osteoarthritis: roccella, a 52-week, randomized, double-blind, dose-ranging phase 2 study. Osteoarthritis and Cartilage. 29. S264–S264. 5 indexed citations
3.
4.
Deckx, H., Ellen van der Aar, María Pueyo, et al.. (2021). The design of a randomized, placebo-controlled, dose-ranging trial to investigate the efficacy and safety of the ADAMTS-5 inhibitor S201086/GLPG1972 in knee osteoarthritis. SHILAP Revista de lepidopterología. 3(4). 100209–100209. 16 indexed citations
5.
Aar, Ellen van der, H. Deckx, Sonia Dupont, et al.. (2021). Safety, Pharmacokinetics, and Pharmacodynamics of the ADAMTS‐5 Inhibitor GLPG1972/S201086 in Healthy Volunteers and Participants With Osteoarthritis of the Knee or Hip. Clinical Pharmacology in Drug Development. 11(1). 112–122. 17 indexed citations
6.
Deckx, H., et al.. (2020). Study design of a phase 2 clinical trial with a disease-modifying Osteoarthritis drug candidate GLPG1972/S201086: The roccella trial. Osteoarthritis and Cartilage. 28. S499–S500. 10 indexed citations
7.
Lalande, Alain, D. Phung, Ellen van der Aar, et al.. (2020). FRI0393 BASELINE CHARACTERISTICS OF THE STUDY POPULATION IN ROCCELLA, A PHASE 2 CLINICAL TRIAL EVALUATING THE EFFICACY AND THE SAFETY OF S201086/GLPG1972 IN PATIENTS WITH KNEE OSTEOARTHRITIS. Annals of the Rheumatic Diseases. 79. 794–795. 1 indexed citations
8.
9.
10.
Zhu, Fengcai, et al.. (2016). Comparative Efficacy, Safety and Immunogenicity of Hepavax-Gene TF and Engerix-B Recombinant Hepatitis B Vaccines in Neonates in China. The Pediatric Infectious Disease Journal. 36(1). 94–101. 6 indexed citations
11.
Orkin, Chloe, David A. Wohl, Andrew E. Williams, & H. Deckx. (2015). Vitamin D deficiency in HIV: a shadow on long-term management?. PubMed. 16(2). 59–74. 14 indexed citations
12.
Sension, Michael & H. Deckx. (2015). Lipid metabolism and lipodystrophy in HIV-1-infected patients: the role played by nonnucleoside reverse transcriptase inhibitors.. PubMed. 17(1). 21–36. 15 indexed citations
13.
Tebas, Pablo, Michael Sension, José Ramón Arribas, et al.. (2014). Lipid Levels and Changes in Body Fat Distribution in Treatment-Naive, HIV-1–Infected Adults Treated With Rilpivirine or Efavirenz for 96 Weeks in the ECHO and THRIVE Trials. Clinical Infectious Diseases. 59(3). 425–434. 49 indexed citations
14.
Nelson, Mark, Richard Elion, C Cohen, et al.. (2013). Rilpivirine Versus Efavirenz in HIV-1–Infected Subjects Receiving Emtricitabine/Tenofovir DF: Pooled 96-Week Data from ECHO and THRIVE Studies. HIV Clinical Trials. 14(3). 81–91. 46 indexed citations
15.
16.
Crauwels, Herta, et al.. (2012). Absence of a pharmacokinetic interaction of rilpivirine with the P‐glycoprotein substrate digoxin in healthy volunteers. Journal of the International AIDS Society. 15(S4). 1–2. 2 indexed citations
17.
Contempré, Bernard, et al.. (1993). Selenium deficiency mitigates hypothyroxinemia in iodine-deficient subjects. American Journal of Clinical Nutrition. 57(2). 271S–275S. 46 indexed citations
18.
Hidajat, M., et al.. (1989). Neonatal Alloimmune Thrombocytopenic Purpura Induced by Anti-Baka: A Case Report and Review of the Literature. Acta Clinica Belgica. 44(6). 377–382. 6 indexed citations
19.
Thilly, Claude Hector, Pierre Bourdoux, Jean Vanderpas, et al.. (1986). Neonatal and juvenile hypothyroidism in Central Africa. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 26–33. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Chen Breakdown of academic impact, for papers by P.P. Koopmans Breakdown of academic impact, for papers by John Ayodele Olaniyi Breakdown of academic impact, for papers by Danny Li Breakdown of academic impact, for papers by Can Küçük Breakdown of academic impact, for papers by Renu Misra Breakdown of academic impact, for papers by Müferet Ergüven Breakdown of academic impact, for papers by Idy Tam Breakdown of academic impact, for papers by Anna-Carin Norlin
Rankless by CCL
2026